Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Monica Capozzi"'
Autor:
Alessandro Ottaiano, Massimiliano Berretta, Claudia Von Arx, Monica Capozzi, Michele Caraglia
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/34bae374e3ac481c813385696db6178e
Autor:
Alessandro Ottaiano, Stefania Scala, Nicola Normanno, Maria Napolitano, Monica Capozzi, Anna Maria Rachiglio, Cristin Roma, Anna Maria Trotta, Crescenzo D’Alterio, Luigi Portella, Carmela Romano, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Anna Nappi, Salvatore Tafuto, Antonio Avallone, Alfonso De Stefano, Mario Tamburini, Carmine Picone, Antonella Petrillo, Francesco Izzo, Raffaele Palaia, Vittorio Albino, Alfonso Amore, Andrea Belli, Ugo Pace, Massimiliano Di Marzo, Paolo Chiodini, Gerardo Botti, Gianfranco De Feo, Paolo Delrio, Guglielmo Nasti
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Combination of chemotherapies (fluoropirimidines, oxaliplatin and irinotecan) with biologic drugs (bevacizumab, panitumumab, cetuximab) have improved clinical responses and survival of metastatic colorectal cancer (mCRC). However,
Externí odkaz:
https://doaj.org/article/c63b96d6390c4ab8b86f568154c6b5fd
Autor:
Alessandro Ottaiano, Monica Capozzi, Salvatore Tafuto, Alfonso De Stefano, Chiara De Divitiis, Carmela Romano, Antonio Avallone, Guglielmo Nasti
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: There are no clinical studies comparing the efficacy of bevacizumab vs.aflibercept in association with folfiri in RAS mutated (RAS-M) metastatic colorectal cancer patients (mCRC) pretreated with folfox and bevacizumab.Patients and Methods
Externí odkaz:
https://doaj.org/article/77365e9b07394e83984d7e9a6f1efe13
Autor:
Monica Capozzi, Chiara De Divitiis, Alessandro Ottaiano, Tramontano Teresa, Maurizio Capuozzo, Piera Maiolino, Gerardo Botti, Salvatore Tafuto, Antonio Avallone, The Abdominal Oncology Group, Rossana Casaretti, Antonino Cassata, Anna Nappi, Guglielmo Nasti, Carmela Romano, Lucrezia Silvestro
Publikováno v:
Frontiers in Public Health, Vol 6 (2018)
Introduction: The therapeutic scenario of Oncology is enriching of innovative agents which are determining an increase in public expenditure because of their high cost. In Italy, a web-based government Registry is used to monitor the clinical use of
Externí odkaz:
https://doaj.org/article/1557ec5b7d5141938c131ba3de255fcb
Autor:
Stefania Cocco, Alessandra Leone, Michela Piezzo, Roberta Caputo, Vincenzo Di Lauro, Francesca Di Rella, Giuseppina Fusco, Monica Capozzi, Germira di Gioia, Alfredo Budillon, Michelino De Laurentiis
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 21, p 7836 (2020)
Breast cancer is a heterogeneous disease consisting of different biological subtypes, with differences in terms of incidence, response to diverse treatments, risk of disease progression, and sites of metastases. In the last years, several molecular t
Externí odkaz:
https://doaj.org/article/3e8da519a6904dde9f41f3b614c582c2
Autor:
Alessandro Ottaiano, Alfonso De Stefano, Monica Capozzi, Anna Nappi, Chiara De Divitiis, Carmela Romano, Lucrezia Silvestro, Antonino Cassata, Rossana Casaretti, Salvatore Tafuto, Michele Caraglia, Massimiliano Berretta, Guglielmo Nasti, Antonio Avallone
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Introduction: We performed a meta-analysis in order to analyze and quantify the effect on survival of starting therapy in RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients with anti-EGFR agents or bevacizumab.Patients and Methods: Rando
Externí odkaz:
https://doaj.org/article/89295854267f4a9ca4ccd1533b09a53c
Autor:
Alessandro Ottaiano, Antonino Cassata, Monica Capozzi, Chiara De Divitiis, Alfonso De Stefano, Antonio Avallone
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
In 2005, we performed the largest survey on clinical trials of biotherapies for all solid tumors and found indirect evidence of a publication bias: editors of medical journals were more prone to publish positive results independently from the quality
Externí odkaz:
https://doaj.org/article/d6b415f5df614e319504b0e6d91b2f69
Autor:
Salvatore Tafuto, Claudia von Arx, Monica Capozzi, Fabiana Tatangelo, Manuela Mura, Roberta Modica, Maria Luisa Barretta, Antonella Di Sarno, Maria Lina Tornesello, Annamaria Colao, Alessandro Ottaiano
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 8, p 1224 (2019)
Background. Platinum-based chemotherapy is the mainstay of front-line treatment of patients affected by pluri-metastatic intermediate/high grade NeuroEndocrine Neoplasms (NENs). However, there are no standard second-line treatments at disease progres
Externí odkaz:
https://doaj.org/article/9be80e4210b44c878a643b54d9ef5611
Autor:
Claudia von Arx, Monica Capozzi, Elena López-Jiménez, Alessandro Ottaiano, Fabiana Tatangelo, Annabella Di Mauro, Guglielmo Nasti, Maria Lina Tornesello, Salvatore Tafuto
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 9, p 1277 (2019)
Neuroendocrine neoplasms (NENs) comprise a heterogeneous group of rare malignancies, mainly originating from hormone-secreting cells, which are widespread in human tissues. The identification of mutations in ATRX/DAXX genes in sporadic NENs, as well
Externí odkaz:
https://doaj.org/article/c2e3fdaac554418f913a84191b7ad50f
Autor:
Ernesta Cavalcanti, Anita Minopoli, Bruna Grilli, Chiara De Divitiis, Gaetano Corso, Luigi Russo, Monica Gelzo, Monica Capozzi, Salvatore Tafuto, Vittoria Barchiesi
Publikováno v:
Clinical Oncology and Research. :1-5
Neuroendocrine tumors (NETs) are a group of neoplasms that originate from neuroendocrine cells. They can occur in various anatomic locations, most commonly in gastro intestinal tract, lungs and pancreas. In NETs associated to the carcinoid syndrome,